BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30008714)

  • 1. Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.
    Dolton G; Zervoudi E; Rius C; Wall A; Thomas HL; Fuller A; Yeo L; Legut M; Wheeler S; Attaf M; Chudakov DM; Choy E; Peakman M; Sewell AK
    Front Immunol; 2018; 9():1378. PubMed ID: 30008714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs.
    Tungatt K; Bianchi V; Crowther MD; Powell WE; Schauenburg AJ; Trimby A; Donia M; Miles JJ; Holland CJ; Cole DK; Godkin AJ; Peakman M; Straten PT; Svane IM; Sewell AK; Dolton G
    J Immunol; 2015 Jan; 194(1):463-74. PubMed ID: 25452566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.
    Rius C; Attaf M; Tungatt K; Bianchi V; Legut M; Bovay A; Donia M; Thor Straten P; Peakman M; Svane IM; Ott S; Connor T; Szomolay B; Dolton G; Sewell AK
    J Immunol; 2018 Apr; 200(7):2263-2279. PubMed ID: 29483360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
    Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
    Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.
    Dolton G; Tungatt K; Lloyd A; Bianchi V; Theaker SM; Trimby A; Holland CJ; Donia M; Godkin AJ; Cole DK; Straten PT; Peakman M; Svane IM; Sewell AK
    Immunology; 2015 Sep; 146(1):11-22. PubMed ID: 26076649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping.
    Bethune MT; Comin-Anduix B; Hwang Fu YH; Ribas A; Baltimore D
    Biotechniques; 2017 Mar; 62(3):123-130. PubMed ID: 28298179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers.
    Lissina A; Ladell K; Skowera A; Clement M; Edwards E; Seggewiss R; van den Berg HA; Gostick E; Gallagher K; Jones E; Melenhorst JJ; Godkin AJ; Peakman M; Price DA; Sewell AK; Wooldridge L
    J Immunol Methods; 2009 Jan; 340(1):11-24. PubMed ID: 18929568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricks with tetramers: how to get the most from multimeric peptide-MHC.
    Wooldridge L; Lissina A; Cole DK; van den Berg HA; Price DA; Sewell AK
    Immunology; 2009 Feb; 126(2):147-64. PubMed ID: 19125886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
    J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
    Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
    Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.
    Holland CJ; Dolton G; Scurr M; Ladell K; Schauenburg AJ; Miners K; Madura F; Sewell AK; Price DA; Cole DK; Godkin AJ
    J Immunol; 2015 Dec; 195(12):5827-36. PubMed ID: 26553072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
    Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
    Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
    Samanta D; Mukherjee G; Ramagopal UA; Chaparro RJ; Nathenson SG; DiLorenzo TP; Almo SC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13682-7. PubMed ID: 21825122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
    J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
    Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
    Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum dot/pMHC multimers vs. phycoerythrin/pMHC tetramers for identification of HLA-A*0201-restricted pHBV core antigen18-27-specific T cells.
    Zhu J; Huang Y; Su J; He J; Yu Y; Zhao Y; Lu X
    Mol Med Rep; 2017 Dec; 16(6):8605-8612. PubMed ID: 28765875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2.
    Weng X; Liang Z; Lu X; Zhong M; Lu S; Zhang C; Deng J; Wu X; Gong F
    Sci China C Life Sci; 2007 Apr; 50(2):203-11. PubMed ID: 17447027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.